# Sputum Matrix Metalloproteinases (MMP) mRNA and Montelukast

> **NCT00947453** · PHASE2 · COMPLETED · sponsor: **University of East Anglia** · enrollment: 15 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** montelukast

## Key facts

- **NCT ID:** NCT00947453
- **Lead sponsor:** University of East Anglia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2012-08-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00947453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00947453, "Sputum Matrix Metalloproteinases (MMP) mRNA and Montelukast". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00947453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*